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Introduction
The human immunodefi  ciency virus (HIV) type 1 genome con-
sists of a single transcription unit that is integrated into cellular 
chromatin. HIV-1 is highly dependent on transcriptional regu-
lation: acutely infected cells synthesize high levels of virus, 
whereas latently infected cells transcribe little or no viral RNAs. 
This tight regulation is a critical feature of viral pathogenicity 
because it allows the virus to remain silent in the organism and 
prevents clearance by the current antiretroviral regimens (for 
review see Greene and Peterlin, 2002; Marcello, 2006).
The HIV-1 promoter is located in the U3 region of the 5′ 
long terminal repeat (LTR). Its transcription is performed by the 
cellular machinery, but it is boosted by the viral protein Tat (for 
reviews see Jeang et al., 1999; Marcello et al., 2001). In latently 
infected cells that do not produce Tat, the polymerases initiating 
at the HIV-1 promoter are unprocessive and unable to transcribe 
the entire viral genome. Lymphocyte-activating stimuli induce 
the HIV-1 promoter to produce small amounts of Tat, which 
starts a positive feedback loop by stimulating viral transcription 
(Weinberger et al., 2005). Tat recruits to the HIV-1 promoter the 
active form of the positive transcription elongation factor P-TEFb 
(Wei et al., 1998), which consists of a complex between cyclin 
T1 and Cdk9 (for review see Peterlin and Price, 2006). Tat binds 
to both cyclin T1 and the trans-activation–responsive region, an 
RNA element present at the 5′ end of all viral transcripts. This 
induces the formation of a tertiary complex on nascent RNAs, 
which brings Cdk9 into position to phosphorylate several com-
ponents of the transcription machinery, including the C-terminal 
domain (CTD) of the large subunit of RNA polymerase II 
(RNAPII), and elongation factors DSIF and negative elongation 
factor (NELF; for review see Peterlin and Price, 2006). This 
converts RNAPII into a highly processive enzyme, which can 
transcribe the entire viral genome.
Production of HIV-1 mRNAs is not only regulated at the level 
of transcription but also at the level of splicing and polyadenylation 
(Schwartz et al., 1990; Ashe et al., 1997). HIV-1 possesses two 
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  R
NA polymerase II (RNAPII) is a fundamental enzyme, 
but few studies have analyzed its activity in living 
cells. Using human immunodeﬁ   ciency virus (HIV) 
type 1 reporters, we study real-time messenger RNA (mRNA) 
biogenesis by photobleaching nascent RNAs and RNAPII 
at speciﬁ  c transcription sites. Through modeling, the use 
of mutant polymerases, drugs, and quantitative in situ 
hybridiza  tion, we investigate the kinetics of the HIV-1 tran-
scription cycle. Initiation appears efﬁ  cient because most 
polymerases demonstrate stable gene association. We cal-
culate an elongation rate of approximately 1.9 kb/min, 
and, surprisingly, polymerases remain at transcription 
sites 2.5 min longer than nascent RNAs. With a total 
polymerase residency time estimated at 333 s, 114 are 
assigned to elongation, and 63 are assigned to 3′-end 
processing and/or transcript release. However, mRNAs 
were released seconds after polyadenylation onset, and 
analysis of polymerase density by chromatin immuno-
precipitation suggests that they pause or lose processivity 
after passing the polyA site. The strengths and limitations 
of this kinetic approach to analyze mRNA biogenesis in 
living cells are discussed.
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polyadenylation sites, one in each LTR. Poly  adenylation at the 
fi  rst site is suppressed by binding of the small nuclear RNP U1 
to the major splice donor (SD1; Ashe et al., 1997), whereas 
polyadenylation at the second site is activated by upstream 
sequences present in the U3 region of the 3′ LTR (Ashe et al., 
1995; Gilmartin et al., 1995).
Many of the regulatory events that determine the fate of 
HIV-1 RNAs occur at the transcription site. This includes the 
decision to initiate transcription, to elongate, to splice, and to 
process the RNA at the 3′ end. Most importantly, the relative 
kinetic rate of each process appears to be critical for their fi  nal 
outcome. For instance, the rate of cleavage at the fi  rst polyA site 
and the rate of U1 binding at SD1 determine the amount of 
read-through at this polyA site (Ashe et al., 1997). Similarly, 
the rate of splicing versus 3′-end formation at the second polyA 
site determines the amount of unspliced RNA available for 
Rev-mediated export (Malim et al., 1989). In these two cases, 
the kinetic competition is infl  uenced by the rate of transcription 
elongation. For instance, cleavage at the fi  rst polyA site cannot 
be suppressed until the polymerase reaches SD1, and splicing 
cannot be competed out by 3′-end formation until the poly-
merase arrives at the second polyA site. Importantly, the rate of 
transcription elongation can be regulated, and this can control 
gene expression (de la Mata et al., 2003; Batsche et al., 2006).
Like HIV-1, many cellular genes are regulated at the level 
of transcription, and transcriptional regulation has been the sub-
ject of a large number of studies. However, although transcrip-
tion by RNAPII is a fundamental process, we still lack a precise 
view of how transcription occurs in vivo. In particular, we lack 
detailed kinetic models describing mRNA synthesis and the 
cycle of RNAPII. In this study, we used FRAP to study these 
processes directly in living cells.
Results
Real-time analysis of mRNA biogenesis by 
photobleaching nascent RNAs
Previous studies have shown that tagging RNA with 24 binding 
sites for the coat protein of phage MS2 allows its detection in 
living cells with excellent sensitivity (Fusco et al., 2003; Shav-
Tal et al., 2004). To analyze the biogenesis of HIV-1 mRNA, 
we inserted 24 MS2-binding sites in the 3′ untranslated   region 
of an HIV vector that carried the elements required for RNA 
production (Fig. 1 A): the 5′ LTR, the major splice donor (SD1), 
the packaging signal Ψ, the Rev-responsive element, the 
splice acceptor A7 fl  anked by its regulatory sequences (exonic 
splicing enhancer and ESS3), and the 3′ LTR that drives 3′-end 
formation. Stable arrays of this reporter construct (pExo-MS2×24) 
were integrated into U2OS cells. Two clones (Exo1 and Exo2) 
showed robust trans-activation by Tat and other stimuli 
known to induce transcription of integrated HIV-1 promoters 
(Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb
.200706018/DC1). When expressed, the RNAs were distributed 
homogenously in the cytoplasm and concentrated in a bright 
spot in the nucleoplasm. This spot corresponded to the tran-
scription site as it colocalized with RNAPII and was labeled 
with probes directed against the nontranscribed strand of the 
vector (Fig. 1 B). Several active genes localize near speckles 
(Smith et al., 1999; Moen et al., 2004). However, the HIV-1 
transcription site rarely colocalizes with speckles labeled by the 
marker protein SC35 (Fig. 1 B).
To visualize nascent HIV-1 RNAs, a nuclear MS2-GFP 
fusion was expressed in Exo1 or Exo2 cells. In live cells, 
MS2-GFP was diffused in the nucleoplasm and concentrated 
in a spot at the transcription site (Fig. 2). FRAP is a   powerful 
technique to study the dynamic properties of a fl  uorescent 
molecule, and we used it to study mRNA synthesis by photo-
bleaching the nascent RNAs labeled with MS2-GFP. Indeed, 
when a transcription site is bleached, incoming polymerases 
will synthesize new MS2 sites, and this will result in recovery 
of the fl  uorescent signal. In this system, RNAs are visualized 
indirectly through MS2-GFP, and this may complicate the 
FRAP analysis (Braga et al., 2007). First, a slow diffusion rate 
of MS2-GFP may mask the neosynthesis of nascent RNAs. 
Second, a rapid dissociation of the RNA-bound MS2-GFP 
may lead to rapid recovery rates unrelated to the synthesis of 
new RNAs.
To obtain an estimate for the rate of exchange of the MS2-
GFP protein on its target site, we used an abundant noncoding 
RNA, U3, which was modifi  ed to incorporate a single MS2-
binding site. U3 is synthesized in the nucleoplasm and accumulates 
Figure 1.  Characterization of HIV-1 transcription sites. (A) Schematics of 
the HIV-1 reporters. (B) HIV-1 transcription sites contain a focal accumula-
tion of mRNAs. Exo1 cells were transfected with a Tat expression vector 
and ﬁ  xed 24 h later. (top) HIV-1 mRNAs and integrated DNA were de-
tected by in situ hybridization. (middle) RNAPII was detected by immuno-
ﬂ  uorescence. (bottom) SC35 does not accumulate at HIV-1 transcription sites. 
Each ﬁ  eld is 22 × 22 μm; insets are magniﬁ  cations of the transcription 
sites (2.5 × 2.5 μm). Proteins were visualized by immunoﬂ  uorescence. 
Bar, 8.8 μm.REAL-TIME VISUALIZATION OF MRNA BIOGENESIS • BOIREAU ET AL. 293
in nucleoli, where it plays essential functions during ribosomal 
RNA biogenesis (Kass et al., 1990). Previous work has shown that 
a fraction of the proteins associated with U3 exchange slowly 
between nucleoli and the nucleoplasm (Phair and Misteli, 2000), 
and it was therefore suspected that a fraction of U3 would also be 
stably associated with nucleoli. When nucleoli of cells expressing 
only MS2-GFP were bleached, fl  uorescence recovery was nearly 
complete within seconds (Fig. S2, available at http://www.jcb
.org/cgi/content/full/jcb.200706018/DC1). In striking contrast, 
when nucleoli of cells expressing both U3-MS2 and MS2-GFP 
were bleached, only a fraction of the fl  uorescence was recov-
ered, even after 10 min. This indicated that a part of U3-MS2 
was immobile and that bleached MS2-GFP molecules stayed 
stably bound to the RNA during the course of the experiment. 
Furthermore, diffusion of MS2-GFP was rapid (15 μm
2/s) and 
much faster than recovery at transcription sites (Fig. 2, A and B). 
Thus, the diffusion or dissociation of MS2-GFP was neglected 
in the analysis of FRAP experiments.
Figure 2.  Analysis of HIV-1 mRNA biogenesis by FRAP of nascent RNAs. Exo1 (A–G) or Exo2 (E, H, and I) cells were transfected with vectors expressing 
Tat and MS2-GFP and analyzed by FRAP. (A and B) FRAP of MS2-GFP analyzed at a high frame rate (160 ms) and on a a short time scale (5 s) with a con-
focal microscope. (A, left) Image of a transfected Exo1 cell (25 × 20 μm). (right) Recovery curves of MS2-GFP in the nucleoplasm of U2OS cells (pink 
curve) or at the HIV-1 transcription sites (blue curve). (B) Snapshot of the FRAP experiment (5 × 2 μm). Left, prebleach; middle, after bleach; right, 5-s time 
point. The bleached area is indicated by a circle (1.5-μm diameter). (C–I) FRAP of MS2-GFP analyzed by tracking transcription sites in 3D for 6 min using 
a wide-ﬁ  eld microscope. (C) Image sequence from a FRAP experiment; each ﬁ  eld is 30 × 25 μm. The time after bleach is indicated together with the 
bleached area (2.5-μm diameter). (D) Recovery curves of MS2-GFP in the nucleoplasm of U2OS cells (pink curve) and at the HIV-1 transcription site (blue 
curve). (E) Comparison of clones Exo1 and Exo2. The postbleach values were set to zero. (F) Schematic of the mRNA biogenesis pathway used to model 
the FRAP curves. (G and H) Fits of Exo1 (G) and Exo2 (H) FRAP curves with single exponential (red curve) and a two-step model that comprises a linear 
increase followed by an exponential (pink and green, respectively). (I) Comparison of experimental (red and blue) and computer-simulated (green) FRAP curves. 
Error bars represent SD. Bar, 7.2 μm.JCB • VOLUME 179 • NUMBER 2 • 2007  294
A substantial fraction of nascent RNAs 
are elongating
Recovery of Exo1 transcription sites showed that the synthe-
sis of new RNAs occurred in <3 min and that virtually no 
RNAs were retained at the transcription site for a long time 
(immobile fraction of 3%; Fig. 2 D). A second clone express-
ing the same MS2-tagged RNA yielded similar kinetics (Exo2; 
Fig. 2 E), indicating that this was principally a property of 
the reporter.
RNA biogenesis occurs in a series of steps: transcription, 
3′-end formation (cleavage and polyadenylation), and release 
from the transcription site (Fig. 2 F). To test whether elongation 
was rate limiting, we used a slow version of RNAPII, the hC4 
mutant (de la Mata et al., 2003). This α-amanitin–resistant 
mutant was transfected in Exo1 cells, endogenous enzymes 
were inactivated with α-amanitin, and remaining transcription 
sites were analyzed by FRAP. As a control, we used another 
α-amanitin–resistant version of RNAPII that has no elongation 
defect (wild type [WT
res]; de la Mata et al., 2003). FRAP curves 
obtained with WT
res or the endogenous polymerase were nearly 
identical (Fig. 3). In contrast, recoveries were markedly slower 
with the hC4 mutant: 129 s for half-recovery versus 75 s for the 
WT
res enzyme. To confi  rm that transcriptional elongation took a 
substantial part of the time that nascent RNAs spent at their 
transcription sites, we used camptothecin. This drug targets 
topoisomerase I, and it transiently cross-links it to DNA. A previ-
ous study has shown that this creates steric road blocks for 
polymerases, which result in increased pausing and a net slow-
down of transcriptional elongation (Capranico et al., 2007). 
  Indeed, when cells were treated with this drug, the recovery of 
nascent RNAs was slower: 170 s for half-recovery in Exo1 cells 
compared with 65 s in the case of untreated cells (Fig. 4 A).
To further establish that elongation was rate limiting, 
we developed a cell line (ExoLong) that integrated a second 
reporter, pExo-MS2 × 24-Long, which differed by 2.4 kb in 
the length of the sequence separating the MS2 repeat and the 
end of the gene. If elongation is rate limiting, the recovery 
should be slower for the long reporter, and the difference should 
represent the time taken to transcribe the additional sequences. 
As expected, transcription sites of ExoLong recovered more 
slowly: 126 s for half-recovery versus 65 s for the short reporter 
(Fig. 4 B). Altogether, these observations demonstrated that 
elongation took a substantial fraction of the time dedicated to 
mRNA production.
A two-step model comprising elongation 
and 3′-end processing can describe 
recoveries of nascent RNAs
In kinetic terms, transcription elongation is the repetition of an 
elementary step: the addition of one nucleotide. The stochastic 
basis of the process implies that the time taken to add a single 
nucleotide is variable and follows an exponential described by 
the rate constant kel. In contrast, when polymerases transcribe 
a large number of nucleotides, the repetition of the elementary 
Figure 3.  Effect of mutants of RNAPII on the synthesis of nascent RNAs. Exo1 cells were transfected with vectors expressing mutant forms of RNAPII, Tat, 
and MS2-GFP and were treated with α-amanitin before FRAP. (top left) Recovery curves of the endogenous and transfected WT
RES RNAPII (orange and blue 
curves, respectively). (top right) Comparison between the WT
RES (blue), hC4 (red), and ∆CTD (green) RNAPII. (bottom) Fit of the two-step model (straight 
line followed an exponential) with WT
RES (left) and hC4 curves (right). Error bars represent SD.REAL-TIME VISUALIZATION OF MRNA BIOGENESIS • BOIREAU ET AL. 295
step creates a statistical averaging such that the time taken to 
synthesize n nucleotides will be virtually constant for all poly-
merases and equal to n/kel. This feature of transcription elon-
gation is distinctive, and it predicts a linear increase in signal 
during FRAP recovery, whereas single-step processes should 
result in exponentials (Fig. S3 B, available at http://www.jcb
.org/cgi/content/full/jcb.200706018/DC1).
Elongation is the fi  rst step of mRNA biogenesis that can 
be observed in our FRAP experiments. Indeed, once the poly-
merase reaches the polyA site, the pre-mRNA is cleaved, poly-
adenylated, and released. These processes occur as a series of single 
steps and, thus, may be modeled as exponentials. We attempted 
to fi  t the FRAP curve with two components: a straight line 
for elongation followed by a single exponential for 3′-end 
  formation and release. This two-step model fi  tted experimental data 
substantially better than a single exponential (Figs. 2, G and H; 
and 3). The short reporter gave 65 to 73 s for elongation 
and 44 to 31 s for the half-time of the exponential in Exo1 and 
Exo2 cells, respectively (Table I). The long reporter yielded 
148 s for elongation and 65 s for the exponential. This trans-
lated into similar elongation rates of 1.79–2.03 kb/min. Cells 
treated with camptothecin or transfected with the slow mu-
tant of RNAPII could also be fi  tted to this two-step model 
(Figs. 3 and 4 A). For the hC4 mutant, it yielded an elonga-
tion rate more than twofold slower than with WT RNAPII 
(0.8 kb/min), which is in agreement with in vitro data (Coulter 
and Greenleaf, 1985).
The proportion of time dedicated to elongation versus 
3′-end processing can also be estimated by direct comparison of 
the short and long reporters. Indeed, if initiation rates are equal, 
the intensity of the MS2 signal at various transcription sites 
should be proportional to the time that the RNA spends there. 
When the curves of the short and long reporters were normal-
ized to their initiation rate, that is, to their initial slopes, the long 
reporter accumulated 1.5 times more RNAs at the transcription 
site (Fig. 4 B). If one assumes that the time required for elonga-
tion is proportional to the RNA length, whereas other steps are 
identical for the two reporters, this value corresponds to half of 
the time spent on elongation for the short reporter and 71% for 
the long one (see Materials and methods). This was in agree-
ment with the values obtained by fi  tting the FRAP curves with 
the two-step model (Table I).
Estimation of the relative rates of 
elongation and 3′-end formation by 
quantitative in situ hybridization
Next, we performed quantitative in situ hybridization with oligo-
nucleotide probes that hybridized along the gene. Incompletely 
transcribed RNAs should yield more signals with probes hybrid-
izing at their 5′ end, whereas full-length RNAs should yield equal 
signals with 5′ and 3′ probes (Femino et al., 1998). Because 
incompletely transcribed RNAs correspond to elongating mole-
cules, whereas full-length RNAs are at the stage of 3′-end pro-
cessing or transcript release, the ratio of 5′ to 3′ probes can be 
used to estimate the relative time taken by elongation versus 
3′-end processing and release. Four sets of Cy3-labeled probes were 
used (Fig. 5): the fi  rst hybridized in exon 1 (E1), the second in the 
intron (I), the third at the splice acceptor site (I-E2), and the last in 
exon 2 (E2), immediately before the active polyA site. When sig-
nals were normalized with a Cy5-labeled probe against the MS2 
repeat, 5′ probes gave 2.2-fold more signal than 3′ probes (Fig. 5). 
To confi  rm this, we hybridized E1-Cy5 and E2-Cy3 probes simul-
taneously, and signals at the transcription sites were normalized to 
signals in the cytoplasm. Again, we found twofold more E1 probe 
at transcription sites (Fig. S4, available at http://www.jcb.org/cgi/
content/full/jcb.200706018/DC1). From these values, we could 
estimate that half of the polymerases that have reached the MS2 
repeat are elongating toward the polyA site, whereas the other half 
are at the stage of 3′-end formation (see Materials and methods), 
which is in agreement with FRAP experiments.
3′-end formation occurs at various rates, 
whereas release of HIV-1 mRNAs occurs 
seconds after the onset of polyadenylation
To further characterize RNA species present at transcription 
sites, we used a probe specifi  c for polyadenylated HIV-1 mRNAs. 
This probe yielded robust signals in the cytoplasm but only 
faint signals at transcription sites (11% of E2 signal; Fig. 5 B). 
This was unlikely the result of a failure of the probe to hybridize 
to its target because the nuclear polyA-binding protein PABN1 
was also not detected there (Fig. 5 B). This indicated that RNAs 
were released rapidly once polyadenylation started. Indeed, with 
a total 3′-end processing time of 63.5 s (Table I), we calculated 
that cleavage/polyadenylation took 54.7 s and mRNA release 
took 8.8 s (see Materials and methods).
Table I. Kinetic parameters derived from FRAP analysis of nascent HIV-1 RNAs
Clone Exo1 Exo1 
Camptoth
Exo2 ExoLong Exo1 
Pol-WT
RES
Exo1 
Pol-hC4
Length to 3′ end (nt) 2,187 2,187 2,187 4,580 2,187 2,187
Immobile fraction (%) 3 10 4 5.5 0 5
t1/2 (s)
a 65 170 63 126 75 129
t1/2 monoexponential (s)
b 60.2 ND 53.3 95.0 ND ND
Linear phase (s)
c 64.6 68 73.3 148.1 70.7 165.1
t mean exponential (s)
c 63.5 189 44.9 93.6 95.9 87.1
t1/2 exponential (s)
c 44 131 31.1 64.9 66.5 60.4
Elongation rate (kb/min)
c 2.03 1.52 1.79 1.85 1.86 0.79
aTime for half-recovery.
bHalf-time of the best monoexponential ﬁ  t.
cParameters derived from the two-step model (a straight line followed by an exponential).JCB • VOLUME 179 • NUMBER 2 • 2007  296
Figure 4.  Elongation is a limiting step in the recovery of nascent RNAs. (A) Recoveries of MS2-GFP in Exo1 cells treated with camptothecin. Cells were 
transfected with vectors expressing Tat and MS2-GFP, treated or untreated with camptothecin, and analyzed by FRAP. (left) Comparison of treated (green) 
with untreated (blue) cells. (right) Treated cells were ﬁ  tted with the two-step model. Pink, straight line; green, exponential component. (B) Comparison of the 
MS2-GFP recovery curves for the short and long HIV-1 reporters. ExoLong cells were transfected with vectors expressing Tat and MS2-GFP and were ana-
lyzed by FRAP. (top left) Comparison of the recovery curves of Exo1 cells (blue), Exo2 (red), and ExoLong (green). (top right) Fit of the long reporter with 
the two-step model. (bottom left) Comparison of Exo1 and ExoLong recovery curves after normalization by the initial slope (initiation rate). (bottom right) 
Comparison of experimental (blue) and computer-simulated (green) FRAP curves for the long reporter. (C) Recoveries of MS2-GFP in HIV-1 reporters lacking U3. 
pTRIP_1_13 cells expressing the ∆U3 reporter (pTRIP) were transfected as described in A and analyzed by FRAP. Error bars represent SD.REAL-TIME VISUALIZATION OF MRNA BIOGENESIS • BOIREAU ET AL. 297
Figure 5.  Measurements of nascent RNA species by quantitative 
in situ hybridization. (A) Schematic of the short reporter with the 
position of the probes indicated. The relative amount of probe 
corresponds to the Cy3/Cy5 (MS2) ratio measured at the tran-
scription site of Exo1 cells. The predicted ratios were estimated 
from an elongation rate of 2.03 kb/min and 63.5 s for 3′-end 
formation (see Materials and methods). (B) Polyadenylated HIV-1 
mRNAs do not accumulate at the transcription site of Exo1 cells. 
(top) Cells were hybridized with a mixture of pA+-Cy3 and MS2-
Cy5 probes. (bottom) Cells expressing PABN1-GFP were hybrid-
ized with an MS2-Cy3 probe. Insets are magniﬁ  cations of the 
transcription sites (2.5 × 2.5 μm). (C) Images of single cells with 
the various HIV-1 probes. Exo1 cells were transfected with Tat 
and hybridized with a mixture of Cy3-/MS2-Cy5 probes. (B and C) 
Field size is 20 × 20 μm. Bar, 6.7 μm.JCB • VOLUME 179 • NUMBER 2 • 2007  298
The CTD of the large subunit of RNAPII has been pro-
posed to connect the polymerase with the 3′-end processing 
machinery (for review see Meinhart et al., 2005). In addition, 
RNAPII lacking the CTD have defects in transcription initiation 
and in elongating through nucleosomal templates (Meininghaus 
et al., 2000). Remarkably, transcription sites generated by this 
RNAPII mutant recovered very slowly after photobleaching 
(half-recovery of 550 s vs. 75 s for WT
res; Fig. 3). A defect in 
initiation should result in lower amounts of fl  uorescent signal at 
the transcription site, but it should not affect the time that poly-
merases spend on the gene. Thus, the defects we observed arose 
from a reduced ability to synthesize or process nascent RNAs, 
which is in agreement with biochemical data.
To confi  rm that alteration of 3′-end processing could 
slow down the release of HIV-1 RNA, we made a reporter con-
taining mutations near the polyA site. Besides the canonical 
AAUAAA and G/U-rich element, HIV-1 contains upstream 
elements that are required for efficient 3′-end formation. 
These elements are present in the U3 region of the LTR, partly 
explaining why the upstream polyA site in the 5′ LTR is not 
used (Ashe et al., 1995; Gilmartin et al., 1995). The removal of 
these activating sequences does not prevent 3′-end formation 
but renders the process ineffi  cient (Gilmartin et al., 1995). 
For instance, polyA sites inserted downstream of the HIV-1 
3′ LTR are normally not used, but they become active when 
the U3 region of the 3′ LTR is removed (Ashe et al., 1995). 
Thus, we created cell lines expressing HIV-1 reporters lacking 
the U3 region in the 3′ LTR (clone pTRIP_1_13). Remarkably, 
when MS2-GFP was bleached at these transcription sites, the 
signal recovered much more slowly than for WT HIV-1   reporters: 
half-recovery took 400 s instead of 65 s (Fig. 4 C). Thus, 
slowing down the rate of 3′-end formation correspondingly 
increased the time that nascent RNAs remained at their tran-
scription site.
Computer-simulated mRNA synthesis
To better understand HIV-1 RNA biogenesis, we simulated 
the behavior of individual polymerases in silico. For each time 
interval, each polymerase could initiate, elongate by one nucleo-
tide, cleave and polyadenylate, and eventually release their 
associated RNA. The probabilities to perform these steps were 
the means of the measured rate constants (see Materials and 
methods). Predicted FRAP curves approximated those obtained 
experimentally with both the short (Fig. 2 I) and long reporters 
(Fig. 4 B). Simulated SDs were also in range with experimental 
ones. Close examination of simulations indicated that a large part 
of the SD was caused by stochastic variation in the total number 
of polymerases on the gene, which affected the prebleach values 
and the extent of recovery.
Interestingly, the parameters measured with the short 
reporter were slightly too rapid to accurately predict the re-
covery curve of the long one (Table I and Fig. 4 B). An expla-
nation for this observation might reside in the fact that RNAPII 
can pause because pausing is expected to be more frequent 
with longer sequences. Another interesting possibility would 
be that the site of integration of the reporter in the genome 
generates some variation in the kinetics of mRNA synthesis 
and processing.
Figure 6.  Dynamic of RNAPII at HIV-1 transcription sites. Exo1 
cells were transfected with vectors expressing GFP-PolII-C and 
MS2-Cherry and were analyzed on a confocal (A) or wide-ﬁ  eld 
microscope (B). (A) FRAP of RNAPII analyzed at a high frame rate 
(160 ms) and on a short time scale (5 s). (left) Image of a trans-
fected cell (25 × 25 μm). (right) Snapshots from a FRAP experi-
ment (8 × 2 μm). The circle indicates the area of bleach. (B) FRAP 
recovery of GFP-PolII-C analyzed by tracking transcription sites in 
3D for 15 min with a wide-ﬁ  eld microscope. (top) Image sequence 
from a FRAP experiment; each ﬁ  eld is 25 × 25 μm. (left graph) 
Recovery curves in the nucleoplasm of transfected U2OS cells 
(pink) or at the HIV-1 transcription site (blue). Data were normal-
ized to prebleach values. (right graph) Comparison of the re-
coveries of nascent RNAs (pink) and the polymerase (blue). Data 
were normalized between pre- and postbleach values. Bar, 9.2 μm.REAL-TIME VISUALIZATION OF MRNA BIOGENESIS • BOIREAU ET AL. 299
FRAP analysis of RNAPII
Although the MS2-GFP FRAP assay provides a direct measure-
ment of RNAPII activity, it provides little information on the 
events that occur either before the polymerase reaches the MS2 
repeat or after it releases its mRNA. To gain a complete view 
of the transcription cycle, we repeated the FRAP assay with 
fl  uorescent subunits of RNAPII. HIV-1 transcription sites were 
identifi  ed with a red variant of MS2 (MS2-mCherry), and GFP-
tagged subunit C of RNAPII was bleached in the nucleoplasm 
or at HIV-1 transcription sites. Recoveries at the HIV-1 tran-
scription site were much slower than in the nucleoplasm, sug-
gesting that most polymerases present at the HIV-1 gene array 
were engaged in transcription (Fig. 6). Interestingly, recovery of 
the polymerase was substantially slower than recovery of nascent 
RNAs: in Exo1 cells, half-recovery took 200 s for the polymerase 
but only 66 s for nascent RNAs.
To extract more information from the recovery curves, 
they were fi  tted with the diffusion/reaction model developed by 
Sprague et al. (2004). This model assumes that the bleached 
spot contains identical binding sites that are equally distributed 
in space, and it allows one to derive diffusion coeffi  cients, bind-
ing time (tb), and the delay between two binding events (td). The 
recovery curves obtained with the subunit C of RNAPII were 
fi  tted to this model (see Materials and methods). In Exo1 cells, 
we found that the polymerase resided for 333 s at the HIV-1 
transcription site and diffused for 10 min before engaging a 
second transcription cycle.
When the residency time of the polymerase was compared 
with that of nascent RNAs, it was obvious that the polymerase 
remained on the gene longer than expected. Indeed, elongating 
through the reporter should take 114 s, and 3′-end formation 
should take 63 s. Thus, 156 s were missing to match the 333 s 
of the residency time of the polymerase. One possibility could 
be that RNAPII proceeds after the 3′ LTR before terminating 
transcription. To test this possibility, we performed chromatin 
immunoprecipitation experiments. As expected, RNAPII was 
enriched within the HIV gene after Tat induction (primer sets 
A and B; Fig. 7 A). Surprisingly however, a PCR fragment located 
220–420 bases downstream of the polyA site did not show a 
comparable enrichment (primer set C), indicating that RNAPII 
stops rapidly after the end of the gene and is released without 
proceeding much through neighboring sequences.
Discussion
MS2-GFP as a tool to analyze the 
dynamics of speciﬁ  c RNAs
FRAP is a powerful tool to analyze the dynamics of tagged 
proteins. In this study, we photobleached MS2-GFP to analyze 
the turnover of nascent mRNAs tagged with the MS2 repeat.   
This supposes that there is little dissociation of the MS2-GFP–RNA 
complex during the course of the experiment. The MS2 protein 
variant we use has a mutation that increases its affi  nity by 7.5-
fold (Table S1, available at http://www.jcb.org/cgi/content/full/
jcb.200706018/DC1; Lim and Peabody, 1994). In addition, the 
RNA-binding site also contains a mutation that decreases the 
off rate of the protein by 100-fold such that the complex has a 
half-life of 7 h at 4°C (Table S1; Lowary and Uhlenbeck, 1987). 
To directly analyze the stability of the complex in vivo, we 
tagged an RNA stably associated with nucleoli (U3) and found 
by FRAP analysis that little dissociation occurred within the 
fi  rst 10 min of the experiment. Although it could be argued that 
the complex might be less stable in the nucleoplasm than in the 
dense nucleoli, analysis of mutant mRNA (clone pTRIP_1_13) 
or polymerase (∆CTD) set a minimal value of 10 min for the 
half-life of the complex in the nucleoplasm. MS2-GFP has also 
been previously used to analyze the diffusion of MS2-tagged 
mRNA in the nucleoplasm (Shav-Tal et al., 2004). Interestingly, 
similar values (although not identical) were obtained when dif-
fusion was measured by single-particle tracking or photoactiva-
tion, which is also in agreement with a slow dissociation rate of 
MS2-GFP in vivo. Thus, the contribution of the dissociation of 
MS2-GFP in the FRAP curves modeled in this study is expected 
to be small and was neglected in the analyses.
Figure 7.  Density of RNAPII along the HIV-1 reporter. (A) RNAPII chromatin 
immunoprecipitation analysis of the HIV-1 reporter. Exo1 cells were in-
cubated with GST-Tat or a mock control and subjected to chromatin immuno-
precipitation with anti-RNAPII and the indicated primer sets (A, B, and C). 
Primer set C is located 220–420 nucleotides after the polyA site. B13 cor-
responds to a control region in the genome. (middle) PCR reactions on the 
input and immunoprecipitated chromatin. The size of the DNA fragments is 
indicated above the panels. (bottom) Quantiﬁ  cation of the PCR reaction 
(mean of two experiments). (B) Schematic of the HIV-1 transcription cycle. 
The promoter, transcribed, and polyA regions of the HIV-1 reporter are 
schematized. The proposed residency times of the polymerases (gray disks) 
in various areas of the gene are indicated.JCB • VOLUME 179 • NUMBER 2 • 2007  300
To analyze the biogenesis of mRNA in live cells and 
real time, we engineered cell lines that contained many copies 
of the reporter integrated in a single place within the chromatin 
(75 copies for Exo1 cells). This amplifi  es the signal such that 
many events become visible by microscopy analysis. For in-
stance, this system can be used to analyze the dynamic of the 
Tat–pTEFb complex on nascent HIV-1 RNAs (Molle et al., 
2007). However, the repeated structure of the transgene 
might affect mRNA biogenesis in unknown ways. Clearly, 
the next frontier will be to perform similar analysis on single-
copy genes.
The use of live cell imaging technologies allows the anal-
ysis of mRNA biogenesis in intact cells and with an unprece-
dented temporal resolution. However, this process is highly 
complex and is composed of a myriad of successive and inter-
connected steps. The drawback of these analyses is therefore 
that it is diffi  cult to separate each step for detailed analysis. 
In addition, complete modeling of mRNA biogenesis yields a 
very large number of variables that cannot be determined and 
measured in a simple FRAP experiment. In this study, we have 
attempted to alleviate these limitations by the use of simplifi  ed 
models, which can thus be constrained by experimental data. 
The reliability of the models was then assessed through the use 
of mutant RNA, mutant polymerases, drugs, and quantitative in 
situ hybridization.
Kinetics of mRNA biogenesis and the 
transcription cycle of RNAPII
In this study, we were able to visualize mRNA transcription and 
processing in real time and single cells by fl  uorescence tagging 
of HIV-1 RNAs. By performing FRAP analysis on RNAPII and 
nascent RNAs through MS2-GFP, we could obtain a view of the 
entire HIV-1 transcription cycle. For this, the polymerase recov-
ery curves were fi  tted with a diffusion- binding model and com-
pared with that of nascent RNAs. This indicated that during the 
333 s that the polymerase resided at the HIV-1 transcription site, 
114 s could be attributed to elongation, and 63 s could be attrib-
uted to 3′-end processing and transcript release. The remaining 
156 s could be the result of initiation or termination. In an 
attempt to discriminate these possibilities, we investigated 
the localization of Xrn2, a 5′ → 3′ exonuclease involved in 
transcription termination (West et al., 2004). Xrn2 is loaded co-
transcriptionally at the end of genes (Luo et al., 2006), and it 
degrades the 3′ cleavage product generated by the 3′-end matu-
ration of mRNAs (West et al., 2004). Interestingly, Xrn2 was 
present only in a minute amount at the HIV-1 transcription site 
(unpublished data), suggesting that termination and polymerase 
release may be rapid. Thus, a large fraction of the missing 156 s 
could be the result of initiation. In this view, as many as 47% of 
the polymerases could be initiating transcription at the promoter, 
34% would be undergoing processive elongation, and 19% 
would be processing the RNA at the 3′-end (Fig. 7 B). However, it 
is equally possible that the steps between pre-mRNA cleavage and 
the entry of Xrn2 account for some of the missing 156 s. Like-
wise, an alternative hypothesis to explain the long residency time of 
the polymerase might be that a fraction of the polymerase would 
reengage transcription on the same gene by a looping mechanism, 
as described in yeast (O’Sullivan et al., 2004; Ansari and 
Hampsey, 2005). Finally, we also cannot exclude that some 
polymerases present at the HIV-1 transcription sites are stalled 
or are involved in as yet uncharacterized but slow processes.
Transcription initiation
We found that although the residency time of the polymerase at 
the HIV-1 gene was 333 s, the diffusion time between two bind-
ing events was 10 min. Previous FRAP experiments of the large 
subunit of RNAPII at random nucleoplasmic sites have indi-
cated that for cellular genes, polymerases should spend only a 
third of their time engaged in transcription (Kimura et al., 2002). 
Because the half-life of transcription was estimated as 20 min, 
it was deduced that polymerases spend as much as 90 min dif-
fusing between two transcriptional cycles (Kimura et al., 2002). 
Thus, initiation at the HIV-1 promoter is nearly 10 times more 
frequent than at cellular genes. This could be caused by a high 
effi  ciency of transcription initiation at the HIV-1 site or, alterna-
tively, by a much higher density of active genes at the HIV-1 
transcription site. Interestingly, we did not detect a rapid com-
ponent in the recovery curves of RNAPII (Fig. 6 A), which 
  corresponds to polymerases undergoing rapid binding and dis-
sociation from the promoter (Darzacq et al., 2007). In contrast, 
the vast majority of polymerases appeared transiently immo-
bilized on the HIV-1 gene and engaged in productive transcrip-
tion. This suggested that the initiation of HIV-1 transcription 
was indeed very effi  cient. A high effi  ciency of initiation would 
be consistent with biochemical studies that have shown that the 
HIV-1 promoter is constantly occupied by the polymerase (Jeang 
et al., 1999; Marcello et al., 2001). In addition, it is well estab-
lished that a major mode of trans-activating the HIV-1 pro-
moter is at the level of elongation through the binding of Tat to 
nascent RNAs, and this requires that the promoter can effi-
ciently initiate transcription (for reviews see Jeang et al., 1999; 
Marcello et al., 2001).
Transcription elongation
By analyzing the turnover of nascent RNAs, we found that 
nascent transcripts were elongated at a rate of 1.89 kb/min. Four 
important controls support these numbers. First, increasing the 
length of the mRNA increased the total synthesis time but 
yielded a similar elongation rate. Second, quantitative in situ 
hybridization indicated that a substantial fraction of nascent 
RNAs were at the level of 3′-end processing or transcript 
release, and the fraction of incompletely transcribed RNAs was 
consistent with the calculated elongation rate. Third, a slow mu-
tant of RNAPII induced a reduced transcription rate. Fourth, 
treating cells with camptothecin, an inhibitor of elongation, also 
reduced the rate of RNA synthesis.
RNAPII is a fundamental enzyme in the cell. However, 
few studies were able to directly measure its activity in vivo. 
In vitro kinetic analyses of human RNAPII have yielded elonga-
tion rates between 0.9 and 1.8 kb/min and have suggested that 
the chemical step is rate limiting (Burton et al., 2005). Our in 
vivo data are in the upper range of these values, indicating that 
RNAPII may work close to its maximal speed. The giant gene 
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to evaluate elongation rates (Tennyson et al., 1995; Mason and 
Struhl, 2005). These studies yielded values of 2.4 and 2 kb/min, 
which is in agreement with our measures. The range of values 
obtained in different biological systems have observed elonga-
tion rates ranging from 1.5 kb/min for living bacteria to 5.7 kb/min 
for eukaryotic ribosomal RNA genes (Dundr et al., 2002; 
Golding et al., 2005). Our model system provides a tool of 
choice for the quantitative analysis of transcription in real time 
and living cells.
In vitro, single-molecule analyses of bacterial RNA poly-
merases have shown that the time taken to transcribe a DNA 
segment can vary substantially between individual molecules, 
and at least part of this variability can be attributed to poly-
merase pausing (Herbert et al., 2006). In higher eukaryotes, 
pausing is also a well-known phenomenon, and there is some 
evidence that the elongation rate can regulate gene expression 
(Batsche et al., 2006). We describe elongation as the repetition 
of an elementary step and model it as a straight line in the 
  re  covery curves. This does not take into account the polymerase 
heterogeneity that can be caused by pausing and may directly 
contribute to the exponential component of the curve. Although 
determining polymerase pausing time may not be easy in many 
cases, it seems that pausing occurs when cells were treated with 
camptothecin. Indeed, in this case, the MS2-GFP FRAP assay 
indicates a large increase in the exponential component of the 
recovery curve. Because camptothecin is believed to physically 
arrest the polymerase, it is tempting to speculate that this increase 
represents pausing.
3′-end processing and termination
3′-end formation is a critical step during mRNA biogenesis, yet 
the rates of this reaction are not known. Our study indicates a 
rapid release of mRNA once polyadenylation is initiated (9 s). 
In contrast, the preceding steps were relatively slow (55 s). 
These steps probably correspond to the cleavage of the pre-
mRNA, as indicated by the much longer residency time of a 
mutant RNA known to have a slow rate of 3′-end cleavage 
(pTRIP_1_13). However, we cannot rule out other possibilities. 
For instance, cleavage could be rapid, but a quality control step 
could occur before polyadenylation and could prevent mRNA 
release. Indeed, yeast data indicate that a quality control step 
occurs at the level of transcript release (Jensen at al., 2001), and 
detailed localization studies in mammalian cells have shown 
that some transcript can accumulate at the transcription site af-
ter detaching from the gene (Smith et al., 1999; Johnson et al., 
2000). It is also possible that the cleaved RNA could be released 
before being polyadenylated.
However, with the most likely possibility being that cleav-
age is slow and rapidly followed by polyadenylation, we esti-
mated that cleavage and release occurred in 55 s and 9 s, 
respectively. Remarkably, when the U3 sequences of the 3′ LTR 
were removed, the rate of 3′-end formation was dramatically 
reduced. The half-life of these RNAs at the transcription site 
was 400 s, against 65 s for WT RNAs. This indicates that the 
cleavage reaction may occur as much as 10 times more slowly 
for the mutant RNAs. This was consistent with previous bio-
chemical analyses that have shown that U3 contains sequences 
that can markedly stimulate 3′-end formation by enhancing the 
recruitment of cleavage and polyadenylation specifi  city factor 
(Gilmartin et al., 1995). Thus, we expect that the rates of 3′-end 
formation and polymerase read-through may differ markedly 
from gene to gene depending on the strength of the polyA site. 
In particular, situations in which alternative splicing regulates 
polyA site usage implies that 3′-end formation at the fi  rst site is 
slow enough to let the polymerase reach the splice junctions.
Remarkably, ChIP analysis of the distribution of RNAPII 
along the HIV-1 gene indicated that the density of polymerases 
dropped sharply a few hundred bases after the polyA site, simi-
lar to what has been observed recently with an HSP70 gene of 
Drosophila melanogaster (Zhang and Gilmour, 2006). Because 
cleavage is estimated at 55 s and elongation is estimated at 
2 kb/min, this suggests that polymerases pause and/or loose 
their processivity after passing the polyA site. This would be 
consistent with several previous studies. First, run-on assays and 
in vitro transcription reactions have suggested that the poly-
merase looses its processivity as it passes the polyA site (Nag 
et al., 2006). Second, pause sites have been found adjacent to 
polyA sites (Gromak et al., 2006). Third, it has recently been 
shown that the 3′-end processing factor Pcf11 and the exonucle-
ase Xrn2 have a role in promoting transcription termination at 
the end of cellular genes (West et al., 2004; Zhang and Gilmour, 
2006) by dismantling paused elongation complexes (Gromak 
et al., 2006; Zhang and Gilmour, 2006). Altogether, our data 
are in agreement with previously proposed models in which the 
3′-end processing machinery would assemble on nascent RNAs, 
whereas the polymerase would pause after passing the polyA 
site. Completion of assembly and pre-mRNA cleavage would 
occur in about one minute, after which the mRNA would be 
rapidly released and the polymerase would be dismantled.
Materials and methods
Cells and plasmids
U2OS cells were cultivated at 37°C in DME containing 10% FCS. For live 
cell imaging, cells were maintained in the same medium, except it did not 
contain riboﬂ   avin and phenol red (Fusco et al., 2003). Stable transfor-
mants were obtained with the calcium-phosphate procedure by cotransfect-
ing a 20-fold excess of the vector of interest with Ptk-Hygro and selecting 
cells with 132 μg/ml hygromycin. Individual clones were expanded, and 
their gene copy number was measured by quantitative PCR using DNA 
from U1 cells as reference (two copies per genome). Exo1 and ExoLong 
contained 75 and 70 copies, respectively.
For live cell experiments, cells were plated on glass, transiently 
transfected with LipofectAMINE with vectors expressing Tat and MS2-GFP, 
and analyzed 24 h later at 37°C in a nonﬂ  uorescent media (Fusco et al., 
2003). For polymerase replacement, cells were treated for 2.5 h with 
100 μg/ml α-amanitin before FRAP. Control experiments showed that this 
was sufﬁ  cient to induce the disappearance of transcription sites in cells that 
did not express α-amanitin–resistant forms of the polymerase. Treatment of 
cells for 2 h with 10 μg/ml actinomycin D resulted in the disappearance 
of the spots in all cases.
Plasmids expressing MS2-GFP and the hC4 and WT
RES mutant of 
RNAPII have been described previously (de la Mata et al., 2003; Fusco 
et al., 2003). Plasmid expressing PABPN1-GFP was a gift from M. Carmo-
Fonseca (Institute of Molecular Medicine, University of Lisbon, Portugal). 
MS2-Cherry and GFP-PolII-C were created with the Gateway system (Invit-
rogen). U3-MS2 was created by inserting a single MS2 site in the apical 
loop of the rat U3B.7 gene. pExo-MS2×24 plasmid was derived from the 
plasmid pEV731 (Jordan et al., 2001) by cloning 24×MS2 repeats into 
the ClaI–XhoI sites. pExo-MS2×24-Long was constructed by inserting 
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internal ribosome entry site from encephalomyocarditis virus, and the thy-
midine kinase from HSV-1 into the unique XhoI site (Marcello and Giaretta, 
1998). The clone pTRIP that lacked U3 sequences in the 3′ LTR originated 
from a similar vector.
Chromatin immunoprecipitation
Chromatin immunoprecipitation analysis was performed on Exo1 cells 
treated with GST-Tat essentially as previously described (Lusic et al., 2003; 
du Chene et al., 2007). Primer set A corresponds to primer sets for Nuc1 
in Lusic et al. (2003) and map to the promoter-proximal region. Primer set 
B corresponds to a region of the vector proximal to the 3′ LTR (primer Bfw 
[5′-C  A  T  G  G  A  G  C  A  A  T  C  A  C  A  A  G  T  A  G  C  -3′] and primer Brv [5′-A  T  C  T  T  G  T  C  T  T-
C  G  T  T  G  G  G  A  G  T  G  -3′]). Primer set C maps 3′ of the 3′ LTR within the back-
bone of the vector (primer Cfw [5′-A  G  C  A  T  C  T  G  G  C  T  T  A  C  T  G  A  A  G  C  A  G  -3′] 
and primer Crv [5′-A  T  C  G  G  T  G  A  T  G  T  C  G  G  C  G  A  T  A  T  A  G  -3′]). Primer set B13 
corresponds to an unrelated genomic region, as described in Lusic et al. 
(2003). Quantiﬁ   cation of immunoprecipitated material was performed 
by semiquantitative PCR and normalized for input DNA and for B13. The 
antibody against RNAPII was purchased from Santa Cruz Biotechnology, 
Inc. (N-20).
In situ hybridization
In situ hybridization was performed as previously described (Fusco et al., 
2003). The formamide concentration was 50% in the hybridization and 
washing mixture except for the pA+ probe (hybridized and washed at 
30% formamide) and the MS2 probe (10% formamide). The sequences of 
the probes were as follows (X stands for amino-allyl-T): HIV_I_E2 (5′-A X G  G  G-
T  T  G  G  G  A  G  G  T  G  G  G  T  C   X G  A  A  A  C  G  A  T  A  A  T  G  G  T  G  A  A  T   X A); HIV_E1a 
(5′-A X G  A  G  A  G  C  T  C  C  T  C  T  G  G   X T  T  C  C  C  T  T  T  C  G  C  T  T   X C  A  A  G  T  C  C  C  T  G  T  T  C   X A); 
HIV_E1b (5′-A X T  C  T  T  G  C  C  G  T  G  C  G  C  G  C  T   X C  A  G  C  A  A  G  C  C  G  A  G  T  C  C  T  G  -
C  G  T   X A); HIV_intron1 (5′-A X T C  T  C  G  C  A  C  C  C  A  T  C   X C T  C  T  C  C  T  T  C  T  A  G  C  C   X 
C  C  G  C  T  A  G  T  C  A  A  A  A  T   X A); HIV_intron2 (5′-A X A  A  C  T  G  C  G  A  A  T  C  G  T   X C  T  A-
G  C  T  C  C  C  T  G  C  T   X G  C  C  C  A  T  A  C  T  A  T  A  T  G  T  T   X A); HIV_Exon2a (5′-A X G  T  G  G-
C  T  A  A  G  A  T  C   X A  C  A  G  C  T  G  C  C  T  T  G  T  A  A  G   X C  A  T  T  G  G  T  C  T  T  A  A  A   X A); 
HIV_Exon2b; (5′-A X A  T  C  T  T  G  T  C  T  T  C  G   X T  G  G  G  A  G  T  G  A  A  T  T  A  G  C  C  C   X T  C  C-
A  G  T  C  C  C  C  C   X A); HIV_pA+ (5′-A X T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T   X T  G  A-
A  G  C  A  C  T  C  A  A  G  G  C  A  A  G  C   X A); MS2 (transcribed strand; 5′-A X 
G  T  C  G  A  C  C  T  G  C  A  G  A  C  A   X G  G  G  T  G  A  T  C  C  T  C  A   X G  T  T  T  T  C  T  A  G  G  C  A  A  T   X A); 
and MS2 (nontranscribed strand; 5′-A X A  G  T  A  T  T  C  C  C  G  G  G   X T  C  A  T  T  A  G  A  -
T  C  C   X A  A  G  G  T  A  C  C  T  A  A  T  T  G  C   X A). The modiﬁ  ed oligonucleotide probes 
for RNA FISH were synthesized by J-M. Escudier (Plateforme de synthèse 
d’Oligonucléotides modiﬁ  és de l’Interface Chimie Biologie de l’ITAV).
For quantitative measurements, 3D image stacks were collected and 
deconvolved with Hyugens (Bitplane AG). Background was removed, and 
the total light intensity at the transcription site was calculated and divided 
by the number of planes. The number of molecules was then computed 
from a calibration curve of the probes (Fusco et al., 2003), or, alternatively, 
transcription site signals were normalized to the ones of the cytoplasm. 
For each probe, 15–40 transcription sites were analyzed.
For Cy3/Cy5 quantiﬁ  cation relative to the MS2-Cy5 probe (Fig. 4), 
cells were hybridized sequentially with the Cy3 and MS2-Cy5 probes 
(the MS2 probes hybridized at the lower stringency than the other probes). 
Images were taken in both channels, and the amount of light at the tran-
scription site was calculated using the same mask for both colors. 
The Cy3/Cy5 ratios were then corrected for the speciﬁ  c activity of each probe 
by measuring the signals of an equimolar solution of the Cy3 and Cy5 
probes under the microscope. The SDs were E1 (0.55), I (1.55), I-E2 (0.35), 
and E2 (0.16).
For the quantiﬁ  cation of E1-Cy5 versus E2-Cy3 (Fig. S4), the two 
probes were hybridized simultaneously, and the signal of the two probes 
at the transcription site was normalized to the amount of signal in the cyto-
plasm. For this, each image stack was summed along the depth axis (z), 
and the projected signal was quantiﬁ  ed along a line (six pixels wide) that 
passed across the transcription site. The two probes were normalized by 
ﬁ  rst removing the background and then equalizing the cytoplasmic signals. 
The surface of the peak at the transcription sites was measured for both 
probes, and the values of exon 1 were divided by that of exon 2.
Immunoﬂ  uorescence and image acquisition of ﬁ  xed cells
Immunoﬂ  uorescence was performed as previously described (Marcello 
et al., 2003). Anti–Pol II (all isoforms) was used at the following dilutions: 
8WG16 at 1:100 and anti-SC35 (Sigma-Aldrich) at 1:100. Fluorescent 
images of ﬁ  xed cells were captured on a 100× NA 1.4 wide-ﬁ  eld microscope 
(DMRA; Leica) equipped with a camera (CoolSNAP HQ; Roper Scientiﬁ  c) 
and was controlled by MetaMorph software (Universal Imaging Corp.). 
Stacks of wide-ﬁ  eld images were deconvolved with Huygens (Bitplane AG) 
and mounted with Photoshop (Adobe).
FRAP experiments
For live cell imaging, cells were maintained at 37°C in appropriate me-
dium (Fusco et al., 2003). Two microscopic setting were used to perform 
FRAP. For analysis of rapid recoveries (Fig. 2, A and B), we used a con-
focal microscope (Meta LSM510; Carl Zeiss MicroImaging, Inc.) with a 
100× NA 1.4 objective. MS2-GFP at transcription sites or in the nucleo-
plasm was bleached at 488 nm in a circle of 1.5-μm diameter at full laser 
power and for one passage (bleaching time of 100 ms). Recoveries were 
measured at a high frame rate (one image for ≤160 ms) and for a short 
time (up to 10 s) using ≤1% of the power of the 488-nm laser line. Images 
were analyzed as previously described (Phair and Misteli, 2000) by re-
cording the ﬂ  uorescence of the bleached region. Background was re-
moved, intensities at each time point were corrected for bleaching by 
dividing them by the total cell ﬂ  uorescence, and these values were ﬁ  nally 
normalized by dividing them with the ﬂ   uorescent intensity before the 
bleach. In Figs. 2 (E–I), 3, and 6 B (right), postbleach values were addition-
ally set to zero.
When recovery of transcription sites had to be recorded for periods 
exceeding 10 s, we used an adapted microscopic setting. A microscope 
(TE200; Nikon) equipped for both confocal and wide-ﬁ  eld imaging was 
used with a 100× NA 1.45 objective. Transcription sites were bleached 
with the confocal port using a circular region of 2.5-μm diameter (bleach-
ing time of 1 s). Recoveries were then recorded in the wide-ﬁ  eld port using 
MetaMorph (Universal Imaging Corp.) with an excitatory light of low inten-
sity. Images were recorded with an EM-CCD camera (Cascade 512K; 
Roper Scientiﬁ  c). Stacks of nine images 0.5 μm apart were collected every 
3 s (one stack took 0.5–1 s). For image analysis, ﬂ  uorescence intensities 
were measured in a small parallelepiped (1 × 1 × 1.5 μm) placed at the 
most intense area of the transcription site. This operation was performed 
automatically by a macro that was created in ImageJ software (National 
Institutes of Health). This automatic tracking of transcription sites in 3D al-
lowed us to correct cell movements and to minimize signal from diffusing 
MS2-GFP. When a nucleoplasmic region devoid of transcription site was 
bleached, the cube was placed at the center of the bleached region. 
The values obtained were then treated and normalized as in the previous 
paragraph except that the postbleach value was taken at the 5-s time 
point. Indeed, at this time, the diffusing pool of MS2-GFP had come back 
very close to its equilibrium, allowing us to neglect the diffusion of MS2-GFP 
in the analysis (Fig. 2). In all ﬁ  gures except Fig. 2 C, the postbleach value 
was set to zero to facilitate comparison of the curves.
Diffusion coefﬁ  cients
Diffusion coefﬁ  cients were measured by FRAP on transfected HeLa cells. 
For 21 μm
2/s of free GFP, we exploited the solution for free diffusion de-
scribed by Soumpasis (1983). For 15 μm
2/s MS2-GFPnls, we exploited the 
solution proposed for the reaction-diffusion model by Sprague et al. (2004).
Curve ﬁ  tting
For the MS2-GFP FRAP experiment, the curve of 10–20 cells were aver-
aged and ﬁ  tted with a straight line followed by an exponential: f(t) = A + 
α × t, t ≤ telong; f(t) = A + α × telong + (B − A − α × telong) × (1 − exp[−α × 
(t − telong)/(B −A − α × telong)]), t > telong. telong is the time point at which 
the line converts into an exponential and corresponds to the length of the 
linear phase. A is the intensity at the zero time point, α is the slope of the 
initial linear part, and B is the immobile fraction. The minimization routine 
of the C++ GNU Scientiﬁ  c Library (http://www.gnu.org/software/gsl/) 
was used for ﬁ  nding the minimum of the chi square. Chi square values 
were 0.06, 0.06, 0.04, 0.01, and 0.04 for Exo1, Exo2, ExoLong, Wt
res, 
and hC4, respectively.
Recovery curves of RNA polymerase at the transcription site were 
ﬁ  tted with the binding-only simpliﬁ  cation of the diffusion/reaction model 
developed by Sprague et al. (2004): f(t) = Ceq × exp[−Koff × t], where Koff 
is the binding off rate and Ceq is the ratio of on and off rates. This model 
was ﬁ  tted with the R (http://www.r-project.org/) nonlinear least squares 
function. This yielded a residency time of 333 s and a delay between two 
binding events of 660 s.
Computer simulations of mRNA biogenesis
The software was written in Metal, a BASIC emulator for Mac computers 
(http://www.iit.edu/~sarimar/GDS/metal.html). It simulated a small pop-
ulation of RNA polymerase molecules using a stochastic model: during 
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probability to perform the next reaction in the pathway. We used the fol-
lowing circular scheme: inactive → ﬁ  rst nucleotide transcribed → second 
nucleotide transcribed...last nucleotide transcribed → pre-mRNA is cleaved 
→ mRNA is released and polymerase is inactive.
The kinetic rates of each step were determined from the experimen-
tal data: elongation by one nucleotide, 31.5 s
−1 (1.89 kb/min); cleavage, 
0.018 s
−1 (54.7 s); and mRNA release, 0.11 s
−1 (8.8 s). To estimate initia-
tion rates, we measured the number of RNA molecules by quantitative in 
situ hybridization using the MS2 probe. We found that a mean of 105 
RNA molecules was present at the transcription site of Exo1 cells (±50). 
Because FRAP experiments estimated that the MS2-tagged RNAs stayed a 
mean of 128 s at this site, the initiation rate was deduced to 0.99 s
−1 for 
the entire array. The total number of polymerases simulated was calculated 
such that 105 molecules of MS2-tagged RNA were present at the transcrip-
tion site at equilibrium. At the start of the simulation, the population of poly-
merase was distributed according to the equilibrium. Then, at each time 
point of the simulation and for each polymerase, a random draw deter-
mined whether the next step of the pathway occurred or not. The probabil-
ities of success were calculated to match the rate constants, and the time 
resolution was small enough to ensure that a single event per polymerase 
could occur. A variable ﬂ  uorescent value was attributed to each polymer-
ase, which corresponded to the number of nucleotides transcribed in the 
MS2 repeat. For the simulation of FRAP, all ﬂ  uorescence was set to zero, 
and recovery was plotted as a function of time. The values obtained were 
treated as experimental data (i.e., normalized between the pre- and post-
bleach values).
Estimation of transcription elongation versus processing/release time by 
direct comparison of the FRAP curves of the short and long reporter
Curves normalized for their initiation rate (the initial slope of the curve) are 
shown in Fig. 4 B and indicate that 1.5 times more RNAs accumulated at 
the transcription site of the long reporter than for the short one. If initiation 
rates are constant, the amount (i) of ﬂ  uorescent RNA at the transcription site 
is proportional to the time interval (t) between the moment polymerase 
reaches the MS2 site and the moment RNA leaves the transcription site. 
Thus, t = k × i, where k is a constant. However, t can be decomposed in 
two components: a variable one as a result of elongation (t1), which is pro-
portional the length (l) of RNA that remains to be transcribed, and a con-
stant time (t2), representing the time required for 3′-end processing and 
release. Thus, k × i = a × l + t2, where a is a constant. Because l is 2,180 
for the short reporter and 4,580 for the long one, it follows that t1 is 1.2 
times t2 for the short reporter and 2.5 times t2 for the long one.
Estimation of elongation versus processing time by quantitative in situ 
hybridization in Exo1 cells
The ratio between 5′ and 3′ probes depends on the relative amount of time 
that the polymerase spends on the transcription site once it reaches these 
hybridization sites. The same hypothesis was made as above by assuming 
that the time that a nascent RNA remains at the transcription site is decom-
posed into a variable part related to elongation and a constant part related 
to all other processes. In this case, the intensity (i) at a given hybridization 
site can be written as k × i = a × l + t2, where l is the length separating 
the hybridization site from the polyA site and k and a are constants. Assum-
ing an elongation rate of 2.03 kb/min and a 3′-end processing time of 
63.5 s (in Exo1 cells), one can calculate the values given in Fig. 5.
Estimation of cleavage and release rates in Exo1 cells
The FRAP curves yield a total time for 3′-end formation and release of 67.3 s 
on average. 3′-end formation can be decomposed in cleavage, polyade-
nylation, and transcript release. This latter rate can be estimated from the 
amount of polyadenylated mRNA present at the transcription site of Exo1 
cells. The polyadenylated species represents 11% of the exon 2 signal, 
meaning that when a polymerase reaches exon 2, the nascent RNA then 
spends 89% of its time completing transcription and 3′-end processing and 
11% as a polyadenylated species. Because the exon 2 probe is 560 nucle-
otides away from the polyA site, it should take polymerases 16.6 s to go 
from there to the polyA site (at 2.03 kb/min; value from Exo1 cells) and 
then a further 63.5 s to process the RNA (value from Exo1 cells). Thus, 
polyadenylated RNAs should remain at transcription sites 11% of 80.1 s 
(i.e., 8.8 s, yielding a rate of 0.11 s
−1). Because a total time of 63.5 s is 
required for 3′ processing, the time required for cleavage/polyadenylation 
was then estimated at 54.7 s (0.018 s
−1).
Online supplemental material
Fig. S1 shows that transcription of HIV-1 mRNA is induced by Tat and 
PMA/ionomycin in Exo1 cells. Fig. S2 shows that MS2-GFP is stably bound to 
its target RNA in vivo. Fig. S3 shows that elongation can be modeled with 
a straight line. Fig. S4 shows quantiﬁ  cation of exon 1 versus exon 2 at the 
HIV-1 transcription site. Table S1 provides RNA binding properties of the 
coat protein of phage MS2. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200706018/DC1.
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